These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

749 related items for PubMed ID: 15492318

  • 1. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines.
    Shai I, Rimm EB, Hankinson SE, Curhan G, Manson JE, Rifai N, Stampfer MJ, Ma J.
    Circulation; 2004 Nov 02; 110(18):2824-30. PubMed ID: 15492318
    [Abstract] [Full Text] [Related]

  • 2. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ, Chen ML, Wang S, Dong J, Zeng P, Hou LW.
    Chin Med J (Engl); 2004 Feb 02; 117(2):163-7. PubMed ID: 14975195
    [Abstract] [Full Text] [Related]

  • 3. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?
    Wu T, Willett WC, Rifai N, Shai I, Manson JE, Rimm EB.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):973-9. PubMed ID: 16949489
    [Abstract] [Full Text] [Related]

  • 4. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study.
    Hadaegh F, Harati H, Ghanbarian A, Azizi F.
    Eur J Cardiovasc Prev Rehabil; 2006 Aug 05; 13(4):571-7. PubMed ID: 16874147
    [Abstract] [Full Text] [Related]

  • 5. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP, Pépin GM, Mahley RW.
    Am Heart J; 2003 Dec 05; 146(6):1052-9. PubMed ID: 14660998
    [Abstract] [Full Text] [Related]

  • 6. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB, Weis SE, Willis JM, Vasenius KA, McConathy WJ.
    J Am Osteopath Assoc; 2002 Jul 05; 102(7):377-84. PubMed ID: 12138952
    [Abstract] [Full Text] [Related]

  • 7. Associations between serum lipids and causes of mortality in a cohort of 3,499 urban Thais: The Electricity Generating Authority of Thailand (EGAT) study.
    Sritara P, Patoomanunt P, Woodward M, Narksawat K, Tulyadachanon S, Ratanachaiwong W, Sritara C, Barzi F, Yamwong S, Tanomsup S.
    Angiology; 2002 Jul 05; 58(6):757-63. PubMed ID: 18216384
    [Abstract] [Full Text] [Related]

  • 8. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
    Ridker PM, Hennekens CH, Buring JE, Rifai N.
    N Engl J Med; 2000 Mar 23; 342(12):836-43. PubMed ID: 10733371
    [Abstract] [Full Text] [Related]

  • 9. Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen/progestin Replacement Study (HERS).
    Shlipak MG, Chaput LA, Vittinghoff E, Lin F, Bittner V, Knopp RH, Hulley SB, Heart and Estrogen/progestin Replacement Study Investigators.
    Am Heart J; 2003 Nov 23; 146(5):870-5. PubMed ID: 14597937
    [Abstract] [Full Text] [Related]

  • 10. Relationship between plasma lipids and all-cause mortality in nondemented elderly.
    Schupf N, Costa R, Luchsinger J, Tang MX, Lee JH, Mayeux R.
    J Am Geriatr Soc; 2005 Feb 23; 53(2):219-26. PubMed ID: 15673344
    [Abstract] [Full Text] [Related]

  • 11. Role of lipid and lipoprotein profiles in risk assessment and therapy.
    Ballantyne CM, Hoogeveen RC.
    Am Heart J; 2003 Aug 23; 146(2):227-33. PubMed ID: 12891189
    [Abstract] [Full Text] [Related]

  • 12. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T.
    Clin Ther; 2007 Aug 23; 29(8):1671-81. PubMed ID: 17919548
    [Abstract] [Full Text] [Related]

  • 13. Achievement of optimal combined lipid values in a managed care setting: is a new treatment paradigm needed?
    Sarawate CA, Cziraky MJ, Stanek EJ, Willey VJ, Corbelli JC, Charland SL.
    Clin Ther; 2007 Jan 23; 29(1):196-209. PubMed ID: 17379061
    [Abstract] [Full Text] [Related]

  • 14. Serum lipid profiles and homocysteine levels in adults with stroke or myocardial infarction in the town of Gombe in northern Nigeria.
    Glew RH, Okolie H, Crossey M, Suberu O, Trujillo M, Pereyra M, Vanderjagt DJ.
    J Health Popul Nutr; 2004 Dec 23; 22(4):341-7. PubMed ID: 15663167
    [Abstract] [Full Text] [Related]

  • 15. The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary events.
    Koro CE, Bowlin SJ, Stump TE, Sprecher DL, Tierney WM.
    Am Heart J; 2006 Mar 23; 151(3):755.e1-755.e6. PubMed ID: 16504648
    [Abstract] [Full Text] [Related]

  • 16. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M, Biri A, Bukan N, Karakoç A, Sancak B, Törüner F, Paşaoğlu H.
    Gynecol Endocrinol; 2005 May 23; 20(5):258-63. PubMed ID: 16019370
    [Abstract] [Full Text] [Related]

  • 17. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
    Ray KK, Cannon CP, Cairns R, Morrow DA, Ridker PM, Braunwald E.
    Arterioscler Thromb Vasc Biol; 2009 Mar 23; 29(3):424-30. PubMed ID: 19122170
    [Abstract] [Full Text] [Related]

  • 18. Lipids, lipoproteins and apolipoproteins among turks, and impact on coronary heart disease.
    Onat A.
    Anadolu Kardiyol Derg; 2004 Sep 23; 4(3):236-45. PubMed ID: 15355827
    [Abstract] [Full Text] [Related]

  • 19. [The Göttingen Risk, Incidence and Prevalence (GRIPS) study. Recommendations for the prevention of coronary heart disease].
    Cremer P, Muche R.
    Ther Umsch; 1990 Jun 23; 47(6):482-91. PubMed ID: 2375005
    [Abstract] [Full Text] [Related]

  • 20. Homocysteine increases the risk associated with hyperlipidaemia.
    Daly C, Fitzgerald AP, O'Callaghan P, Collins P, Cooney MT, Graham IM, COMAC Group.
    Eur J Cardiovasc Prev Rehabil; 2009 Apr 23; 16(2):150-5. PubMed ID: 19276985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.